![]() |
市场调查报告书
商品编码
1625298
2030 年结晶纤维素市场预测:按原料类型、形式、製程、应用、最终用户和地区进行的全球分析Microcrystalline Cellulose Market Forecasts to 2030 - Global Analysis By Source Type (Wood-based and Non-wood-based), Form, Process, Application, End User and By Geography |
根据 Stratistics MRC 的数据,2024 年全球结晶纤维素 (MCC) 市场规模将达到 9 亿美元,预计在预测期内将以 8.3% 的复合年增长率成长,到 2030 年将达到 15 亿美元。
结晶纤维素 (MCC) 是精製纤维素,是一种存在于植物细胞壁中的天然聚合物。它是通过将木浆或棉花中的纤维素水解成更小的结晶颗粒而生产的。这些颗粒被加工成精细的白色粉末,用于食品、製药和化妆品行业。 MCC 具有独特的性能,如吸湿性、高表面积以及对热和压力的稳定性。它在食品中用作填充剂、粘合剂和稳定剂,在药物中用作锭剂崩坏,并在化妆品中起到增稠和纹理作用。
印度政府预计,到2030年,印度医药产业市场规模预计将达到1,300亿美元。印度也向200多个国家出口药品,未来可能会继续这样做。
製药和食品饮料行业的需求不断扩大
结晶纤维素是製药工业的重要成分,在锭剂中用作粘合剂、崩坏和填充剂。随着人口老化和慢性疾病导致全球药品需求增加,对MCC的需求也增加。由于其稳定性、易于吞嚥和控制释放,它对于锭剂和胶囊至关重要。此外,随着药物传递系统变得更加复杂,MCC 越来越多地融入药物配方中,以提高生物有效性并控製药物释放。
替代品的可用性
单株纤维素 (MCC) 替代品的出现加剧了价格竞争,导致许多产品以更低的价格提供或提高了成本效益比。这种利润压力可能会促使製造商转向更便宜的替代品,从而降低供应商的利润并降低 MCC 的吸引力,尤其是在成本敏感的市场。此外,更便宜的替代品的出现也可能威胁中小型 MCC 製造商的市场占有率,因为他们可能难以与更便宜的替代品竞争。
对天然和有机产品的需求不断增长
结晶纤维素是一种植物来源的天然产品,因其无毒且生物分解性而越来越受欢迎。 MCC 由木浆和棉花製成,符合人们对天然材料日益增长的偏好。 MCC 被认为是一种安全的天然成分,并已成为植物来源产品的热门选择。 MCC 的吸引力在食品和製药行业尤其强劲,天然配方是这些行业的首选,从而推动了市场成长。
潜在的健康问题
结晶纤维素(金属涂层碳酸盐)可能会导致某些人胃肠道不适,并被认为会导致消化器官系统出现问题。因此,消费者会避免含有MCC的产品。儘管 MCC 是惰性的,但它在食品、药品和化妆品中的存在可能会引起注重健康的消费者的担忧,因为他们更喜欢由易于消化和吸收的材料製成的产品。这可能会降低消费者对 MCC 的信心,尤其是在洁净标示和天然产品趋势下。
COVID-19 的影响
COVID-19 大流行扰乱了结晶纤维素 (MCC) 市场,影响了生产、供应链和需求。随着生产放缓和消费者行为转向必需产品,製药和食品行业对 MCC 的需求出现波动。然而,由于营养补充剂和增强免疫力食品等健康产品的增加,MCC 对药品和营养补充剂的需求增加。此外,供应链问题导致了采购问题,但随着製造业的恢復,復苏已经取得进展,随着对天然和有机材料的兴趣增加,需求也趋于稳定。
预计木材领域在预测期内将是最大的
由于对有机、洁净标示和环保产品的需求不断增长,预计木质材料在预测期内将以最高水准增长。然而,对用于结晶纤维素生产的木材对环境影响的担忧,例如森林砍伐和过度捕捞,可能会带来挑战,并且存在对使用影响较小或更永续的原材料生产结晶纤维素的需求。
预计反应挤出领域在预测期内复合年增长率最高。
预计反应挤出领域在预测期内将出现最高复合年增长率,因为它改善了 MCC 的黏度和流动特性,增加了其在食品、药品和化妆品领域的多功能性。这使得 MCC 作为增稠剂、稳定剂和乳化剂更加有效。此外,透过改变颗粒尺寸和形状,可以改善在锭剂和药物被覆剂等各种基质中的分散性。透过使粒径更细或更均匀,可以改善药物控制释放剂和食品的性能,从而导致这些领域的需求增加。
由于北美在慢性病治疗、人口老化和医疗成本上升方面的作用,预计在预测期内将占据最大的市场占有率。 FDA 和加拿大卫生署等监管机构已确保其安全性,使其成为药品製造商的首选辅料。学名药生产的成长通常需要结晶纤维素等高品质辅料,这正在推动该地区的需求。
在註重健康的消费者的推动下,亚太地区预计在预测期内将保持最高的复合年增长率。 MCC 是一种天然衍生成分,用于低脂乳製品、无麸质烘焙点心、食品和饮料以及加工食品,可在不牺牲品质的情况下增强质地并减少热量。人们对除了基本营养之外还具有健康益处的机能性食品越来越偏好,这是亚太地区结晶纤维素市场的主要驱动力。
According to Stratistics MRC, the Global Microcrystalline Cellulose Market is accounted for $0.9 billion in 2024 and is expected to reach $1.5 billion by 2030 growing at a CAGR of 8.3% during the forecast period. Microcrystalline cellulose (MCC) is a refined form of cellulose, a natural polymer found in plant cell walls. It is produced by hydrolyzing cellulose from wood pulp or cotton, breaking it down into smaller crystalline particles. These particles are processed into a fine white powder, used in food, pharmaceuticals, and cosmetics industries. MCC has unique properties like moisture absorption, high surface area, and stability under heat and pressure. It is used as a bulking agent, binder, and stabilizer in food products, as well as in pharmaceuticals for tablet disintegration and in cosmetics for thickening and texturizing effects.
According to the Government of India, the Indian pharma industry's market size is expected to reach USD 130 billion by 2030. India has also sent pharmaceutical products to more than 200 countries, and it may do so again in the future.
Growing demand in pharmaceuticals & food and beverage industry
Microcrystalline cellulose is a crucial component in the pharmaceutical industry, used as a binder, disintegrant, and filler in tablet formulations. With the global demand for pharmaceuticals increasing due to an aging population and chronic diseases, MCC demand is also increasing. It is crucial in tablets and capsules for stability, ease of swallowing, and controlled release. Moreover as the focus shifts to advanced drug delivery systems, MCC is being incorporated into formulations to improve bioavailability and control drug release.
Availability of substitutes
The availability of substitutes for monoclonal cellulose (MCC) has led to increased price competition, with many products being offered at lower prices or with better cost-benefit ratios. This pressure on profit margins can lead manufacturers to shift to cheaper alternatives, reducing supplier profit margins and potentially reducing the attractiveness of MCC, especially in cost-sensitive markets. Additionally, the availability of cheaper alternatives could threaten the market share of small- and medium-sized producers of MCC, as they may struggle to compete with more affordable substitutes.
Rising demand for natural and organic products
Microcrystalline cellulose, a natural, plant-derived product, is gaining popularity due to its non-toxic, biodegradable nature. It is derived from wood pulp or cotton, aligning with the growing preference for natural ingredients. MCC is perceived as a safe, natural ingredient, making it a popular choice for plant-based products. Its appeal is particularly strong in the food and pharmaceutical industries, where natural formulations are preferred encouraging the market growth.
Potential health concerns
Microcrystalline Cellulose, or metal-coated carbonate, can cause gastrointestinal distress in some individuals, leading to a perception of digestive issues. This can cause consumers to avoid MCC-containing products. Despite being inert, its presence in food, medications, and cosmetics can raise concerns among health-conscious consumers who prefer products made from digestible or absorbable substances. This could reduce consumer trust in MCC, especially in the context of clean-label and natural product trends.
Covid-19 Impact
The COVID-19 pandemic disrupted the Microcrystalline Cellulose (MCC) market, affecting production, supply chains, and demand. Pharmaceutical and food industries saw fluctuating demand for MCC as production slowed and consumer behaviour shifted toward essential products. However, the rise in health-focused products, such as dietary supplements and immune-boosting foods, boosted demand for MCC in pharmaceuticals and nutraceuticals. Additionally, supply chain challenges led to sourcing issues, but recovery is underway as manufacturing resumes, and demand stabilizes with growing interest in natural and organic ingredients.
The wood-based segment is expected to be the largest during the forecast period
The wood-based is expected to be the largest during the forecast period owing to the driving demand for organic, clean-label, and eco-friendly products. However, concerns about the environmental impact of sourcing wood for microcrystalline cellulose production, such as deforestation and overharvesting, may pose a challenge, driving demand for alternative sources of microcrystalline cellulose using less impactful or more sustainable raw materials.
The reactive extrusion segment is expected to have the highest CAGR during the forecast period
The reactive extrusion segment is expected to have the highest CAGR during the forecast period as it improves the viscosity and flow properties of MCC, making it more versatile in food, pharmaceuticals, and cosmetics. This makes MCC more effective in thickening agents, stabilizers, and emulsifiers. Modified particle size and shape can also enhance its dispersion in various matrices, such as tablets or pharmaceutical coatings. Finer or more uniform particle sizes can enhance performance in controlled drug release and food products, leading to increased demand in these sectors.
North America is anticipated to hold the largest market share during the forecast period due to its role in treating chronic diseases, aging populations, and rising healthcare costs. Regulatory agencies like the FDA and Health Canada ensure its safety, making it a preferred excipient for formulators. The growth in generic drug production, which often requires high-quality excipients like microcrystalline cellulose further, boosts demand in the region.
Asia Pacific is expected to hold the highest CAGR over the forecast period driven by health-conscious consumers. MCC, a naturally derived ingredient, is used in low-fat dairy, gluten-free baked goods, beverages, and processed foods to enhance texture and reduce calorie content without compromising quality. The growing preference for functional foods with health benefits beyond basic nutrition is a key driver of the microcrystalline cellulose market in APAC.
Key players in the market
Some of the key players in Microcrystalline Cellulose market include Accent Microcell, Ankit Pulps, Apollo Scientific Ltd, Asahi Kasei Corporation, Blanver, Chemfield Cellulose, DFE Pharma, DuPont, Fengchen Group Co., Ltd., Foodchem International Corporation, Godavari Biorefineries LTD, International Flavors & Fragrances Inc, JRS PHARMA, Roquette Freres, SEPPIC and VWR International, LLC
In December 2024, Asahi Kasei has received governmental support for the expansion of its manufacturing capacity for cell frames and membranes of alkaline water electrolyzers for the production of green hydrogen at its plant site in Kawasaki, Japan.
In November 2024, Chiome Bioscience Inc. and Asahi Kasei Pharma Corporation announced that they have entered into an exclusive license agreement to develop and commercialize Chiome's humanized anti-CX3CR1 antibody (hereinafter referred to "PFKR" as Chiome's project code), currently in the preclinical stage.
In November 2024, DuPont announced the launch of Tyvek(R) with Renewable Attribution (RA), an extension of the existing portfolio of Tyvek(R) products for healthcare packaging that offers a significantly reduced carbon footprint, helping to enable more sustainable healthcare packaging.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.